BioSpace News Archive

Business

Takeda Selects Five New Partnerships for Annual Global Corporate Social Responsibility (CSR) Program, Supporting Disease Prevention to Improve Health in Developing and Emerging Countries

Takeda’s founding mission to serve patients, wherever they are, drives its increased commitments to disease prevention, capacity building, and access to healthcare in developing and emerging countries, in partnership with the global community.

June 27, 2019
·
11 min read
Genetown

Sage Therapeutics to Host “Sage FutureCast” Webcast

Event will provide an R&D and portfolio review across the depression, neurology and neuropsychiatric franchises

June 27, 2019
·
1 min read
Policy

Canadian Cancer Society calls on all federal parties to make cancer a priority this election

The Canadian Cancer Society is urging political party leaders to make cancer a priority this federal election.

June 27, 2019
·
3 min read
Pharm Country

NYU Langone Health Launches New Center to Study the Drivers and Consequences of the National Opioid Epidemic

Watch a video of Dr. Magdalena Cerdá outline the mission and goals of the Center for Opioid Epidemiology and Policy

June 27, 2019
·
5 min read
Deals

Blue Earth Diagnostics to be Acquired by Global Leader Bracco Imaging

Blue Earth Diagnostics, a molecular imaging diagnostics company, announced that a definitive agreement has been signed for Bracco Imaging S.p.A.

June 27, 2019
·
8 min read
Business

Surterra Wellness Raises $100 Million in Series D Funding to Accelerate its Growth in U.S. and International Markets

Surterra Wellness (Surterra), one of the fastest growing health and wellness companies in the United States (U.S.), today announced the initial closing of a $100 million Series D funding round and the expansion of its Board of Directors.

June 27, 2019
·
4 min read
Business

NEOMED-LABS and Public Health England Announce a Strategic Agreement

NEOMED-LABS and Public Health England’s National Infection Service are pleased to announce that they have entered into a strategic partnership to engage in the improvement of global human health.

June 27, 2019
·
3 min read
Business

Hoth Therapeutics, Inc. Enters into Sponsored Research Agreement with the George Washington University

Company Analyzing Efficacy of Aprepitant in Reducing Skin-Related Disorders Attributed to Cancer Treatment

June 27, 2019
·
4 min read
Drug Development

Catabasis Pharmaceuticals Provides Update on Global Phase 3 PolarisDMD Trial for Edasalonexent at Parent Project Muscular Dystrophy 25th Annual Conference

Patient Identification Nearing Completion for Global Phase 3 PolarisDMD Trial for Edasalonexent in Duchenne Muscular Dystrophy

June 27, 2019
·
8 min read
Drug Development

Xeris Pharmaceuticals Doses First Patient in Phase 2 Trial Evaluating Its Developmental Ready-to-use Glucagon in Patients at Risk From Hypoglycemia Following Bariatric Surgery

Xeris Pharmaceuticals, Inc. announced that is has dosed the first subject in a Phase 2 trial with its developmental ready-to-use glucagon in patients who experience hypoglycemic episodes following bariatric surgery.

June 27, 2019
·
6 min read